BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16234823)

  • 1. Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study.
    Katsumata N; Noda K; Nozawa S; Kitagawa R; Nishimura R; Yamaguchi S; Aoki D; Susumu N; Kuramoto H; Jobo T; Ueki K; Ueki M; Kohno I; Fujiwara K; Sohda Y; Eguchi F
    Br J Cancer; 2005 Oct; 93(9):999-1004. PubMed ID: 16234823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of docetaxel in advanced or metastatic endometrial cancer.
    Hamed RH; Abdelkhalek SE
    Hematol Oncol Stem Cell Ther; 2012; 5(3):146-51. PubMed ID: 23095790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of weekly docetaxel in patients with recurrent or metastatic endometrial cancer: AGO Uterus-4.
    Günthert AR; Ackermann S; Beckmann MW; Camara O; Kiesel L; Rensing K; Schröder W; Steiner E; Emons G;
    Gynecol Oncol; 2007 Jan; 104(1):86-90. PubMed ID: 16996111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of epirubicin in combination with weekly docetaxel for patients with advanced NSCLC who have failed or relapsed after the frontline platinum-based chemotherapy.
    Lin CM; Chen CH; Chang JW; Tsao TC
    Am J Clin Oncol; 2009 Apr; 32(2):169-73. PubMed ID: 19307958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage chemotherapy with docetaxel and epirubicin for advanced/metastatic gastric cancer.
    Lim JY; Cho JY; Paik YH; Lee DK; Lee SI; Park HJ; Lee SJ; Lee KS; Yoon DS; Choi SH
    Oncology; 2007; 73(1-2):2-8. PubMed ID: 18332648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma.
    Pierga JY; Diéras V; Beuzeboc P; Dorval T; Palangié T; Jouve M; Scholl SM; Garcia-Giralt E; Pouillart P
    Gynecol Oncol; 1997 Aug; 66(2):246-9. PubMed ID: 9264570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.
    Smith RE; Anderson SJ; Brown A; Scholnik AP; Desai AM; Kardinal CG; Lembersky BC; Mamounas EP
    Clin Breast Cancer; 2002 Dec; 3(5):333-40. PubMed ID: 12533263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel monotherapy as a second-line treatment after failure of fluoropyrimidine and platinum in advanced gastric cancer: experience of 154 patients with prognostic factor analysis.
    Jo JC; Lee JL; Ryu MH; Sym SJ; Lee SS; Chang HM; Kim TW; Lee JS; Kang YK
    Jpn J Clin Oncol; 2007 Dec; 37(12):936-41. PubMed ID: 18211985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of weekly docetaxel for patients with advanced or recurrent cancer of the cervix.
    Pearl ML; Johnston CM; McMeekin DS
    Gynecol Obstet Invest; 2007; 64(4):193-8. PubMed ID: 17664880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer.
    Guardiola E; Peyrade F; Chaigneau L; Cupissol D; Tchiknavorian X; Bompas E; Madroszyk A; Ronchin P; Schneider M; Bleuze JP; Blay JY; Pivot X
    Eur J Cancer; 2004 Sep; 40(14):2071-6. PubMed ID: 15341981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor.
    Cui Y; Li Q; Yu Y; Chen Y; Feng Y; Wang Y; Liu T
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):145-52. PubMed ID: 23064955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer.
    Park KW; Ahn JS; Park YS; Lee J; Kang JH; Park JO; Lim HY; Im YH; Kang WK; Park K; Lee SI
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):17-21. PubMed ID: 16721549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Hitt R; Amador ML; Quintela-Fandino M; Jimeno A; del Val O; Hernando S; Cortes-Funes H
    Cancer; 2006 Jan; 106(1):106-11. PubMed ID: 16329139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel in advanced or metastatic endometrial cancer: Clinical Outcome (Mansoura University).
    Hamed RH; Elkhalk SA; Roshdy S
    Gulf J Oncolog; 2013 Jan; 1(13):23-9. PubMed ID: 23339978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy.
    Lee JL; Ryu MH; Chang HM; Kim TW; Yook JH; Oh ST; Kim BS; Kim M; Chun YJ; Lee JS; Kang YK
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):631-7. PubMed ID: 17520252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Garcia AA; Blessing JA; Vaccarello L; Roman LD;
    Am J Clin Oncol; 2007 Aug; 30(4):428-31. PubMed ID: 17762444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
    Pectasides D; Xiros N; Papaxoinis G; Pectasides E; Sykiotis C; Koumarianou A; Psyrri A; Gaglia A; Kassanos D; Gouveris P; Panayiotidis J; Fountzilas G; Economopoulos T
    Gynecol Oncol; 2008 May; 109(2):250-4. PubMed ID: 18299146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II evaluation of weekly docetaxel in the treatment of recurrent or persistent endometrial carcinoma: a study by the Gynecologic Oncology Group.
    Garcia AA; Blessing JA; Nolte S; Mannel RS;
    Gynecol Oncol; 2008 Oct; 111(1):22-6. PubMed ID: 18675446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Specenier P; Rasschaert M; Vroman P; Van den Brande J; Dyck J; Schrijvers D; Huizing MT; Vermorken JB
    Am J Clin Oncol; 2011 Oct; 34(5):472-7. PubMed ID: 20938321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel and platinum combination chemotherapy in locally advanced or metastatic head and neck cancer.
    Kucukzeybek Y; Gorumlu G; Karaca B; Erten C; Cengiz E; Kemal Gul M; Karabulut B; Uslu R; Sanli UA; Goker E
    J BUON; 2008; 13(2):199-203. PubMed ID: 18555465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.